Home » Topics » Disease categories and therapies » Immune

Immune
RSS

FDA issues health alert over Menactra

Oct. 13, 2005

Novel immunomodulatory agents claimed

Oct. 11, 2005

Cerus and The University of New Mexico to develop tularemia vaccine

Oct. 10, 2005

Innogenetics extends collaboration with IDM Pharma

Oct. 6, 2005

Five reports of Guillain-Barre syndrome following administration of Menactra

Oct. 5, 2005

Japanese National Institute of Infectious Diseases to study Ampligen

Oct. 5, 2005

LigoCyte receives NIH grant for intranasal anthrax vaccine

Oct. 5, 2005

Amarillo updates low dose oral interferon progress

Oct. 5, 2005

Lck inhibition prevents acute rejection of heart transplants

Sep. 29, 2005

Pentacel BLA accepted for filing

Sep. 29, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...